Stock analysis, AI verdict, fundamentals & technical signals
Rating: HOLD
Price: $42.18 Analyst target: $44.97 Upside: 6.61%
Novo Nordisk A / S, a healthcare company, is dedicated to the research, development, manufacture and marketing of pharmaceutical products globally. The company is headquartered in Bagsvaerd, Denmark.
See the full interactive analysis & chart →Informational only — not investment advice.